The Science of Head Trauma

Research nears a biomarker for the contact-sport-associated disease that affects athletes long after they’ve retired.

Written byEd Yong
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Houston Texans vs. Dallas CowboysWIKIMEDIA, AJ GUELIn May 2012, former National Football League (NFL) player Junior Seau shot himself in the chest. An autopsy, conducted by the National Institutes of Health, revealed that Seau suffered from chronic traumatic encephalopathy (CTE)—a condition where repeated blows to the head, even mild ones, can trigger the progressive loss of brain tissue. He was the latest of a number of former athletes who have taken their own lives and were the discovered to have the neurological hallmarks of the disease. The string of suicides has pushed awareness of CTE to fever pitch, and earlier this week, the NFL and General Electric jointly pledged $60 million over 4 years to research on diagnosing and treating brain trauma.

CTE has a long history. It was first documented in the 1920s by New Jersey medical examiner Harrison Martland, who noticed that boxers slowly developed a form of dementia after repeated blows to the head. Described initially as “punch drunk” or “dementia pugilistica,” the condition was later renamed as CTE after researchers realized that it could be caused by activities other than boxing. The recent discovery that young athletes can also suffer from the condition has spurred a surge of interest. “The field has exploded,” said Ann McKee from Boston University. “It can’t believe what’s happened in 5 years.”

Since 2008, McKee and colleagues a “brain bank” at the Center for the Study of Traumatic Encephalopathy (CSTE), based at Boston University School of Medicine, have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo